Brain Blood Flow in Newborns Exposed to Opioids Before Birth
Part of Mental health clinical trials.
This study looks at how opioid exposure during pregnancy affects blood flow and brain function in newborns. Researchers will compare babies exposed to opioids in the womb with babies who were not exposed, to better understand how prenatal opioid exposure affects the developing brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby was born at 36 weeks of pregnancy or later (term or near-term birth)
- Baby weighed more than 2 kg (about 4.4 lbs) at birth
- Mother was at least 19 years old during pregnancy
- Baby's APGAR score (a health check right after birth) was 7 or higher at 5 minutes
- Baby has no major birth defects or genetic conditions
- Baby did not need breathing assistance in the delivery room
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the placenta and baby's development may be affected when a mother takes buprenorphine or methadone for opioid use disorder during pregnancy. It aims to find better ways to monitor health and improve outcomes for both mothers and babies.
This study looks at different medicine approaches to treat newborns with opioid withdrawal (NOWS). It compares how well babies do with standard care and may help find the best way to manage symptoms and support recovery.
This study looks at tiny genetic signals (microRNA) in newborn samples to identify neonatal opioid withdrawal syndrome. It may help doctors recognize withdrawal sooner, so babies can get the right care faster.
This study looks at whether supportive interventions can affect brain “plasticity,” or how the brain adapts, in mothers who are in treatment for opioid use disorder. If you qualify, you may be asked to take part in assessments and follow-up so researchers can better understand recovery during early motherhood.
This study looks at pregnancy and baby outcomes for people who are pregnant and taking buprenorphine for opioid use disorder. It may help doctors understand what to expect long-term for both parent and child when opioid treatment continues during pregnancy.
This study tests a postpartum intervention for mothers diagnosed with opioid use disorder (or receiving opioid addiction treatment) to help during the period after having a baby. You may be eligible if you have a young child and can complete the study tasks, including possible questionnaires and an MRI if needed.
Hear when a new Neonatal Opioid Withdrawal Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.